CytoSorbents
≡
  • Home
  • About
    • About Us
    • Board
    • Executive Management
    • Advisors
    • Our Partners
    • Intellectual Property
  • Products
    • CytoSorb
    • HemoDefend
    • ECOS-300CY
    • DrugSorb
    • VetResQ
  • Technology
    • Power of the Bead
    • Product Pipeline
    • Focus: CytoSorb-XL
    • Focus: K+ Sorbent
  • Investor Relations
    • Overview
    • Events & Presentations
    • Analyst Coverage
    • Financial Results
    • Videos
    • SEC Filings
    • Stock Quote
    • Investor FAQ
    • Corporate Governance
  • News
    • Press Releases
    • Publications
    • White Papers
    • Press Kit
    • Media
  • Contact
    • Contact Us
    • Become A Partner
    • Career Opportunities

Investor Relations

  • Home
  • contact
CytoSorbents is a leader in critical care immunotherapy. The company is committed to serving the best interests of our patients and their families, our customers, our employees, and our shareholders.

CytoSorb® is a unique blood purification therapy.The product is currently approved in the European Union and distributed in 58 countries around the world

X
U.S. FDA Grants CytoSorb® Emergency Use Authorization for Use in Patients with COVID-19 Infection. Call 848-667-8990 to Order.